CooperCompanies, a prominent name on the Nasdaq under the ticker COO, stands as a vital player in the healthcare industry, specifically in medical devices. Founded in 1958, the company is headquartered in the United States and distinguishes itself through its two primary business units: CooperVision and CooperSurgical. These units focus on the contact lens sector and fertility and women's health, respectively, serving more than fifty million lives annually.
The company has a significant global footprint, distributing products to over 130 countries, driven by a workforce of over 15,000 individuals. Notably, CooperCompanies received a $1.50B Post-IPO Equity investment on December 17, 2021. Their commitment to innovation and healthcare evolution is demonstrated by accolades like the Fast Company Best Workplace for Innovators and recognition as an Inspiring Workplace.
For investors, CooperCompanies presents a solid opportunity through its established market presence and progressive vision for enhancing global well-being.